3.34
price down icon3.75%   -0.13
after-market 시간 외 거래: 3.40 0.06 +1.80%
loading
전일 마감가:
$3.47
열려 있는:
$3.44
하루 거래량:
107.66K
Relative Volume:
0.73
시가총액:
$126.12M
수익:
-
순이익/손실:
$-27.66M
주가수익비율:
-3.5158
EPS:
-0.95
순현금흐름:
$-24.36M
1주 성능:
+0.30%
1개월 성능:
+13.61%
6개월 성능:
-15.66%
1년 성능:
+73.96%
1일 변동 폭
Value
$3.30
$3.45
1주일 범위
Value
$3.30
$3.70
52주 변동 폭
Value
$1.60
$5.885

Genelux Corp Stock (GNLX) Company Profile

Name
명칭
Genelux Corp
Name
전화
805-267-9889
Name
주소
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
Name
직원
24
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
GNLX's Discussions on Twitter

GNLX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GNLX
Genelux Corp
3.34 131.03M 0 -27.66M -24.36M -0.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Genelux Corp Stock (GNLX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-10-29 개시 Guggenheim Buy
2024-08-28 개시 ROTH MKM Buy
2023-11-27 개시 H.C. Wainwright Buy
2023-09-12 개시 Maxim Group Buy
2023-02-15 개시 The Benchmark Company Speculative Buy

Genelux Corp 주식(GNLX)의 최신 뉴스

pulisher
Jul 24, 2025

What drives Genelux Corporation stock priceBreakthrough investment results - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Genelux Corporation Stock Analysis and ForecastTriple returns potential - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Genelux stock maintains Buy rating at H.C. Wainwright amid sector news - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

Genelux stock maintains Buy rating at H.C. Wainwright amid sector news By Investing.com - Investing.com South Africa

Jul 23, 2025
pulisher
Jul 23, 2025

Promising Prospects for Genelux Corp.’s Olvi-Vec: A Buy Rating Based on Strong Clinical Trial Design and Efficacy - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Genelux Corporation stockOutstanding risk-reward balance - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 21, 2025

Lucid Capital Initiates Coverage on Genelux with a Buy Rating, Setting a Price Target of $10. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Lucid Capital Initiates Coverage of Genelux with Buy Rating and $10 Price Target - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Genelux: LUCID CAPITAL MARKETS Initiates Buy Coverage, PT $10 - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Lucid Capital Markets initiates Genelux stock with Buy rating, $10 target By Investing.com - Investing.com South Africa

Jul 21, 2025
pulisher
Jul 21, 2025

Genelux initiated with a Buy at Lucid Capital - TipRanks

Jul 21, 2025
pulisher
Jul 20, 2025

Is Genelux Corporation a good long term investmentExceptional portfolio growth - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Genelux Corp: A Promising Investment in the Oncolytic Virus Space with Key Clinical Milestones Ahead - TipRanks

Jul 19, 2025
pulisher
Jul 19, 2025

What risks could impact Genelux Corporation stock performanceExpert Trading Flow - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

Genelux Corporation (NASDAQ:GNLX) Position Trimmed by Stratos Wealth Partners LTD. - Defense World

Jul 18, 2025
pulisher
Jul 15, 2025

Why Genelux Corporation stock attracts strong analyst attentionProven Win Setups - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Genelux Corporation stock price move sharplyFree VIP Investment Strategies - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Genelux (NASDAQ:GNLX) Raised to “Hold” at Wall Street Zen - Defense World

Jul 12, 2025
pulisher
Jul 08, 2025

Amgen Alum Takes Legal Reins of Biotech Firm Developing Cancer Treatment - Law.com

Jul 08, 2025
pulisher
Jul 07, 2025

Genelux Appoints Groen as General Counsel From Rani Therapeutics - Bloomberg Law News

Jul 07, 2025
pulisher
Jul 07, 2025

Biopharma Co. Genelux Hires Life Sciences Veteran As GC - Law360

Jul 07, 2025
pulisher
Jul 07, 2025

Genelux appoints Eric Groen as general counsel, corporate secretary, CCO - TipRanks

Jul 07, 2025
pulisher
Jul 07, 2025

Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development - MarketScreener

Jul 07, 2025
pulisher
Jul 07, 2025

Former Amgen $10B Deal Architect Joins Genelux Leadership to Drive Strategic Growth - Stock Titan

Jul 07, 2025
pulisher
Jul 07, 2025

Genelux Corporation Appoints Eric Groen as General Counsel and Head of Business Development - Quiver Quantitative

Jul 07, 2025
pulisher
Jul 02, 2025

Genelux Corporation (NASDAQ:GNLX) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jul 02, 2025
pulisher
Jun 16, 2025

June 2025's Promising Penny Stocks For Savvy Investors - simplywall.st

Jun 16, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Sells 18,446 Shares of Genelux Co. (NASDAQ:GNLX) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Citadel Advisors LLC Lowers Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Millennium Management LLC Cuts Stake in Genelux Co. (NASDAQ:GNLX) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Genelux Co. (NASDAQ:GNLX) Shares Sold by Squarepoint Ops LLC - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

Wall Street Zen Downgrades Genelux (NASDAQ:GNLX) to Sell - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Genelux Co. (NASDAQ:GNLX) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Genelux (NASDAQ:GNLX) Trading Up 3.3% – Time to Buy? - Defense World

Jun 06, 2025
pulisher
Jun 02, 2025

Genelux Corporation (GNLX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Jun 02, 2025
pulisher
May 14, 2025

Top Executives at Genelux Corp. Unload Thousands of Shares! - TipRanks

May 14, 2025
pulisher
May 13, 2025

GENELUX Corp Executives Sell Shares to Cover Taxes - TradingView

May 13, 2025
pulisher
May 10, 2025

Genelux Q3 EPS Raised by Brookline Capital Management - Defense World

May 10, 2025
pulisher
May 10, 2025

HC Wainwright Issues Optimistic Outlook for Genelux Earnings - Defense World

May 10, 2025
pulisher
May 09, 2025

Genelux Corp.’s Promising Prospects: Buy Rating Backed by Strong Phase 3 Trial and Financial Position - TipRanks

May 09, 2025
pulisher
May 08, 2025

Genelux (GNLX) Price Target Lowered by Benchmark Analyst | GNLX Stock News - GuruFocus

May 08, 2025
pulisher
May 07, 2025

Promising Developments in Genelux Corp.’s Olvi-Vec Drive Buy Rating - TipRanks

May 07, 2025
pulisher
May 07, 2025

H.C. Wainwright lifts Genelux stock target to $31, maintains buy By Investing.com - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

H.C. Wainwright lifts Genelux stock target to $31, maintains buy - Investing.com

May 07, 2025
pulisher
May 06, 2025

Genelux reports Q1 EPS (21c), consensus (24c) - TipRanks

May 06, 2025
pulisher
May 06, 2025

Genelux (GNLX) Shows Strong Progress in Cancer Treatment Trials | GNLX Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Genelux Reports 71% Disease Control Rate in Lung Cancer Trial, Q1 2025 Earnings | GNLX Stock News - Stock Titan

May 06, 2025
pulisher
May 06, 2025

Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates - Yahoo Finance

May 06, 2025
pulisher
May 02, 2025

Geode Capital Management LLC Has $716,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World

May 02, 2025
pulisher
May 01, 2025

Genelux CEO Discusses Next-Gen Immuno-Oncology Pipeline and Key Milestones at Citizens Conference - Stock Titan

May 01, 2025
pulisher
Apr 30, 2025

LPL Financial LLC Has $222,000 Stock Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Apr 30, 2025

Genelux Corp (GNLX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Genelux Corp 주식 (GNLX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Zindrick Thomas
President and CEO
May 12 '25
Sale
2.92
10,764
31,431
191,447
Yu Yong
VP, Clinical Trial Operations
May 12 '25
Sale
2.92
5,579
16,291
47,640
Cappello Joseph
VP, Pharmaceutical Development
May 12 '25
Sale
2.92
4,737
13,832
52,266
Smalling Ralph
Head of Regulatory
May 12 '25
Sale
2.92
1,259
3,676
34,760
Tyree James L
Director
Dec 30 '24
Sale
2.46
3,460
8,512
45,791
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):